In one paragraphArticle in medRxiv : the preprint server for health sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
13 authors.
Christine TedijantoFrancis I. Proctor Foundation, University of California San Francisco, San Francisco, CA, USA.ORCID 0000-0003-3403-5765 Sarah GwynDivision of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, USA.ORCID 0000-0002-1856-3165 Dionna M WittbergFrancis I. Proctor Foundation, University of California San Francisco, San Francisco, CA, USA.ORCID 0000-0002-9887-5993 Zerihun TadesseThe Carter Center Ethiopia, Addis Ababa, Ethiopia.
Ambahun ChernetThe Carter Center Ethiopia, Addis Ababa, Ethiopia.
Isabel J B ThompsonFrancis I. Proctor Foundation, University of California San Francisco, San Francisco, CA, USA.
Thomas M LietmanFrancis I. Proctor Foundation, University of California San Francisco, San Francisco, CA, USA.ORCID 0000-0001-8216-0240 Diana L MartinDivision of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Jeremy D KeenanFrancis I. Proctor Foundation, University of California San Francisco, San Francisco, CA, USA.ORCID 0000-0002-7118-1457 Benjamin F ArnoldFrancis I. Proctor Foundation, University of California San Francisco, San Francisco, CA, USA.ORCID 0000-0001-6105-7295 Funding
Sanitation, Water, and Instruction in face-washing for trachoma II (SWIFT II)UG1EY023939 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KEENAN, JEREMY DAVID · 2019 to 2023
$4.1MSeroepidemiology of trachoma for the elimination endgameR01AI158884 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ARNOLD, BENJAMIN F · 2021 to 2025
$2.0MNEI NIH HHS UG1 EY023939NIAID NIH HHS R01 AI158884
6 · The paper itselfAbstract
Monitoring trachoma transmission with antibody data requires characterization of decay in IgG to
Indexed as
antibodyChlamydia trachomatisEthiopiaIgGseroepidemiologytrachoma
Identifiers
PMID36798251
PMCPMC9934712
What OpenQuestion holds
Textmetadata
LicenceCC0
Read underepoch 390